These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Design, synthesis, and evaluation of indolebutylamines as a novel class of selective dopamine D3 receptor ligands. Du P; Xu L; Huang J; Yu K; Zhao R; Gao B; Jiang H; Zhao W; Zhen X; Fu W Chem Biol Drug Des; 2013 Sep; 82(3):326-35. PubMed ID: 23663349 [TBL] [Abstract][Full Text] [Related]
5. Synthesis and characterization of selective dopamine D2 receptor antagonists. 2. Azaindole, benzofuran, and benzothiophene analogs of L-741,626. Vangveravong S; Taylor M; Xu J; Cui J; Calvin W; Babic S; Luedtke RR; Mach RH Bioorg Med Chem; 2010 Jul; 18(14):5291-300. PubMed ID: 20542439 [TBL] [Abstract][Full Text] [Related]
6. In vitro pharmacological profile of YM-43611, a novel D2-like receptor antagonist with high affinity and selectivity for dopamine D3 and D4 receptors. Hidaka K; Tada S; Matsumoto M; Ohmori J; Tasaki Y; Nomura T; Usuda S; Yamaguchi T Br J Pharmacol; 1996 Apr; 117(8):1625-32. PubMed ID: 8732269 [TBL] [Abstract][Full Text] [Related]
7. Synthesis and structure-activity relationships of naphthamides as dopamine D3 receptor ligands. Huang Y; Luedtke RR; Freeman RA; Wu L; Mach RH J Med Chem; 2001 May; 44(11):1815-26. PubMed ID: 11356115 [TBL] [Abstract][Full Text] [Related]
8. Design and synthesis of trans-N-[4-[2-(6-cyano-1,2,3, 4-tetrahydroisoquinolin-2-yl)ethyl]cyclohexyl]-4-quinolinecarboxamide (SB-277011): A potent and selective dopamine D(3) receptor antagonist with high oral bioavailability and CNS penetration in the rat. Stemp G; Ashmeade T; Branch CL; Hadley MS; Hunter AJ; Johnson CN; Nash DJ; Thewlis KM; Vong AK; Austin NE; Jeffrey P; Avenell KY; Boyfield I; Hagan JJ; Middlemiss DN; Reavill C; Riley GJ; Routledge C; Wood M J Med Chem; 2000 May; 43(9):1878-85. PubMed ID: 10794704 [TBL] [Abstract][Full Text] [Related]
9. Dopamine receptor ligands. Part 18: (1) modification of the structural skeleton of indolobenzazecine-type dopamine receptor antagonists. Robaa D; Enzensperger C; Abul Azm Sel D; El Khawass el S; El Sayed O; Lehmann J J Med Chem; 2010 Mar; 53(6):2646-50. PubMed ID: 20180564 [TBL] [Abstract][Full Text] [Related]
10. Examining the Effects of Sodium Ions on the Binding of Antagonists to Dopamine D2 and D3 Receptors. Newton CL; Wood MD; Strange PG PLoS One; 2016; 11(7):e0158808. PubMed ID: 27379794 [TBL] [Abstract][Full Text] [Related]
11. Design and synthesis of novel N-sulfonyl-2-indoles that behave as 5-HT Saavedra OM; Karila D; Brossard D; Rojas A; Dupuis D; Gohier A; Mannoury la Cour C; Millan MJ; Ortuno JC; Hanessian S Bioorg Med Chem; 2017 Jan; 25(1):38-52. PubMed ID: 28029458 [TBL] [Abstract][Full Text] [Related]
12. Interactive SAR studies: rational discovery of super-potent and highly selective dopamine D3 receptor antagonists and partial agonists. Bettinetti L; Schlotter K; Hübner H; Gmeiner P J Med Chem; 2002 Oct; 45(21):4594-7. PubMed ID: 12361386 [TBL] [Abstract][Full Text] [Related]
13. Synthesis, in silico, and in vitro studies of novel dopamine D Elek M; Djokovic N; Frank A; Oljacic S; Zivkovic A; Nikolic K; Stark H Arch Pharm (Weinheim); 2021 Jun; 354(6):e2000486. PubMed ID: 33615541 [TBL] [Abstract][Full Text] [Related]
15. Synthesis and characterization of selective dopamine D2 receptor antagonists. Vangveravong S; McElveen E; Taylor M; Xu J; Tu Z; Luedtke RR; Mach RH Bioorg Med Chem; 2006 Feb; 14(3):815-25. PubMed ID: 16288878 [TBL] [Abstract][Full Text] [Related]
16. 1-(3-Cyanobenzylpiperidin-4-yl)-5-methyl-4-phenyl-1, 3-dihydroimidazol-2-one: a selective high-affinity antagonist for the human dopamine D(4) receptor with excellent selectivity over ion channels. Carling RW; Moore KW; Moyes CR; Jones EA; Bonner K; Emms F; Marwood R; Patel S; Patel S; Fletcher AE; Beer M; Sohal B; Pike A; Leeson PD J Med Chem; 1999 Jul; 42(14):2706-15. PubMed ID: 10411491 [TBL] [Abstract][Full Text] [Related]
17. Synthesis and D2-like binding affinity of 4,5-dihydro-1H-benzo[g]indole-3-carboxamide derivatives as conformationally restricted 5-phenyl-pyrrole-3-carboxamide analogs. Pinna GA; Curzu MM; Sechi M; Chelucci G; Vianello P; Maciocco E Farmaco; 1998; 53(10-11):684-9. PubMed ID: 10205854 [TBL] [Abstract][Full Text] [Related]
18. Synthesis and pharmacological evaluation of potent and highly selective D3 receptor ligands: inhibition of cocaine-seeking behavior and the role of dopamine D3/D2 receptors. Campiani G; Butini S; Trotta F; Fattorusso C; Catalanotti B; Aiello F; Gemma S; Nacci V; Novellino E; Stark JA; Cagnotto A; Fumagalli E; Carnovali F; Cervo L; Mennini T J Med Chem; 2003 Aug; 46(18):3822-39. PubMed ID: 12930145 [TBL] [Abstract][Full Text] [Related]
19. Azepinoindole derivatives with high affinity for brain dopamine and serotonin receptors. Maryanoff BE; McComsey DF; Martin GE; Shank RP Bioorg Med Chem Lett; 1998 Apr; 8(8):983-8. PubMed ID: 9871525 [TBL] [Abstract][Full Text] [Related]